Evidence for Improved Patient Quality of Life With Prostate Cancer Drug
Abiraterone acetate in combination with prednisone delays pain progression as well as health-related quality of life compared with prednisone alone in prostate cancer patients, a new study shows.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news
More News: Abiraterone Acetate | Cancer | Cancer & Oncology | Health | Pain | Prednisone | Prostate Cancer | Study